Opthea (ASX:OPT) secures up to US$260m in funding for OPT-302 trials
Biopharmaceutical company Opthea (OPT) receives binding commitments for a US$90 million (A$127…
Opthea Limited (ASX:OPT)
About Opthea Limited
Key Information
OPT In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 19/12/2024 | Opthea to Present at 43rd J.P. Morgan Healthcare Conference | 273.99KB | 1.7K |
| 17/12/2024 | Change of Director's Interest Notice - SS | 1020.49KB | 290 |
| 17/12/2024 | Change of Director's Interest Notice - SO | 1020.48KB | 221 |
| 17/12/2024 | Change of Director's Interest Notice - QO | 1020.94KB | 186 |
| 17/12/2024 | Change of Director's Interest Notice - LG | 839.63KB | 177 |
| 17/12/2024 | Change of Director's Interest Notice - JH | 1022KB | 160 |
| 17/12/2024 | Change of Director's Interest Notice -AT | 1021.52KB | 174 |
| 17/12/2024 | Change of Director's Interest Notice - JL | 1022.6KB | 187 |